DLA Piper has advised Qualcomm Technologies, Inc. on its participation in NEURA Robotics’ Series C financing round of up to US$1.4 billion, a transaction requiring coordinated corporate, regulatory and intellectual property advice across several jurisdictions. DLA Piper announced the mandate on 17 June 2026. NEURA Robotics has described the financing as the largest funding round to date for a full-stack robotics company and said the proceeds will support increased production of cognitive and humanoid robots, expansion of its Neuraverse platform and wider deployment of physical artificial intelligence applications. Qualcomm Technologies is a subsidiary of Qualcomm Incorporated and supplies semiconductor, connectivity and AI computing technology across industrial and consumer markets. The round brought together investors from technology, manufacturing and institutional finance. NEURA Robotics named Tether, Qualcomm Technologies, Amazon, NVIDIA, imec.xpand, Bosch, Schaeffler, the European Investment Bank, Lingotto Horizon and InterAlpen Partners among the participants. Their involvement reflects the legal demands created when robotics businesses move from research and development towards commercial production, including intellectual property ownership, data use, export controls, foreign investment screening, governance rights and the allocation of liability between developers, manufacturers and users. Corporate partners Simon Vogel and Benjamin Parameswaran led DLA Piper’s team, with associate Maria Uhlig forming part of the core group. The wider team included Semin O on litigation and regulatory matters; Thilo von Bodungen and Kokularajah Paheenthararajah on intellectual property and technology; and Jeff Baglio and Larry Nishnick on US corporate matters. Counsel Thilo Streit, senior associate Monika Marincic and associates Romano Nicklas and Pia Riemenschneider also worked on the transaction. The mandate reflects a broader change in technology financing. Large AI and robotics investments now demand advice beyond conventional venture capital documentation because products may be deployed across factories, healthcare settings, logistics networks and consumer environments. Investors and portfolio companies must assess how contractual rights interact with product liability, cybersecurity, data protection, competition law and regulatory approvals in each market. Legal teams may also need to address how training data, machine-generated information and software updates are controlled after deployment. Solicitors advising on comparable transactions will need to test governance provisions, information rights, intellectual property protections and regulatory conditions before capital is committed. In-house counsel must coordinate those workstreams with commercial teams and technical specialists, while barristers may become involved where regulatory challenges or contractual disputes emerge. For law firm management, the transaction underlines the commercial value of integrated cross-border teams capable of combining deal execution with specialist technology and regulatory advice as physical AI businesses pursue larger and more complex funding rounds.

Source: Lawyer Monthly

Read Original Source →